Topic:

R&D

Latest Headlines

Latest Headlines

Struggling GlaxoSmithKline warns of 150 R&D/commercial job cuts in Philadelphia

Close to three months after GlaxoSmithKline revealed that it is making deep cuts in its R&D group in North Carolina as part of a major reorganization in the U.S., the pharma giant detailed plans to ax up to 150 more staffers and shutter units in its commercial/R&D group in the Philadelphia area.

Berkeley, UCSF researchers develop smart bandage to prevent and monitor bedsores

Engineers have created a smart bandage to detect and assess tissue damage from pressure ulcers before it can be seen by human eyes. This early detection could make recovery easier and more possible; the technology could also be used to monitor an existing bedsore.

Teleflex says its new tool for laparoscopic surgery will help minimally invasive approach gain traction

Teleflex announced that its FDA-cleared minimally invasive surgical system for laparoscopic surgery is officially in use. The device was just used for the first time at the Cleveland Clinic, though as a part of an evaluation of the tool.

Tablets, apps being deployed to improve customer service in the ICU

Hospitals across the country are deploying apps and health information technology to the intensive care unit with a goal of humanizing healthcare and improving interactions with patients and their families.

Soon-Shiong's NantWorks deepens its immuno-oncology ties with Sorrento

Billionaire biotech entrepreneur Patrick Soon-Shiong is expanding his company's relationship with Sorrento Therapeutics, promising $110 million in cash and equity in exchange for the rights to some cancer-fighting immunotherapies.

Study: Newest drug-coated stents as effective as bypass surgery in coronary artery disease

The catheter-based insertion of one of the latest generation of drug-coated stents is just as effective as bypass surgery in treating coronary artery disease, according to a study in the latest issue of the New England Journal of Medicine. That was not the case with the prior generations of bare metal or first-generation drug-eluting stents.

New optogenetics technique does away with genetic modification

The growing field of optogenetics involves the use of light to control neural activity, a process that has wide implications for treating genetic diseases such as macular degeneration. But up until now, the therapy has required the use of genetically modified neurons, limiting its effectiveness in the human population.

'Nest for medical devices' launches out of Y Combinator

The latest company out of famed tech accelerator Y Combinator is a med tech: Shift Labs. The startup aims to make medical devices connected, streamlined and intuitive, much like Google's Nest has done for household thermostats, according to an article in TechCrunch.

CAR-T player Kite Pharma buys its way into Europe and pads its anticancer arsenal

Kite Pharma, a leader among companies in the fast-moving field of cancer immunotherapy, is expanding its arsenal of potential treatments and making European landfall with a biotech buyout.

Efforts at intracochlear drug delivery to treat hearing loss gaining momentum

The millimeters-wide opening of the inner ear has long stymied efforts at drug delivery, but progress is being made, according to Scientific American. Draper Lab is working to create a small intracochlear device designed to treat hearing loss.